MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202517057125 A) filed by Sitryx Therapeutics Limited, Oxford, U.K., on June 13, for 'substituted pyridines for use in treating or preventing inflammatory diseases or diseases associated with an undesirable immune response.'
Inventor(s) include Cooke, Michael Liam; and Mazzacani, Alessandro.
The application for the patent was published on Sept. 26, under issue no. 39/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: (I) wherein, (II), RA1, RA2, RC and RD are as defined herein."
The patent application was internationally filed on Dec. 15, 2023, under International application No.PCT/GB2023/053261.
Disclaimer: Curated by HT Syndication.
